Amgen India Secures ₹200 Million Funding to Accelerate Global Digital Transformation and Innovation

Amgen India is thrilled to announce a major milestone in its ongoing journey toward digital innovation—a successful funding round that raised 200,000,000 to accelerate the company’s ambitious digital transformation agenda. Located in Hyderabad, our cutting-edge technology and innovation site serves as a linchpin in Amgen’s global strategy to deploy advanced technology solutions and digital capabilities, ultimately empowering us to serve more patients worldwide. This infusion of capital will directly fuel significant enhancements across the enterprise, particularly in leveraging state-of-the-art innovations in artificial intelligence, data science, and life sciences. With this funding, our teams are poised to build and scale groundbreaking solutions that not only bolster operational efficiencies but also ensure that our research and development efforts remain at the forefront of biotechnology advancements. The funding will enable Amgen India to intensify its focus on critical areas, develop robust digital platforms, and invest in emerging technologies that are essential to our mission of transforming patient care on a global scale. This initiative underscores our commitment to fostering a culture of innovation, where digital excellence and technological prowess converge to drive meaningful improvements in healthcare outcomes. We invite professionals who are passionate about shaping the future of biotechnology to explore exciting career opportunities at Amgen India. For more details about our career openings, please visit our careers page at https://careers.amgen.com/en/india. As always, we value transparency and encourage you to review our social media guidelines (https://wwwext.amgen.com/community-guidelines) and privacy statement (https://www.amgen.co.in/privacy-statement) for further information.